The forecast for Modulators of the Genital System and Sex Hormones Sales in Italy from 2024 to 2028 shows a steady decline, starting at 87.6 million Euros in 2024 and dropping to 73.1 million Euros in 2028. Compared to the actual sales of 90 million Euros in 2023, the market is experiencing a consistent year-on-year decrease. Specifically, the sales are expected to fall by 4.6% from 2024 to 2025, 4.5% from 2025 to 2026, 4.3% from 2026 to 2027, and 4.3% from 2027 to 2028, resulting in a compound annual growth rate (CAGR) of approximately -4.3% over the 5-year period.
Future trends to watch for include potential impacts of new healthcare policies in Italy, advancements in alternative treatments, and shifts in consumer behavior towards more holistic approaches that could further influence market demand.
